Latest Regulatory Progress News

LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.

Bio-Gene Technology Limited has advanced its bio-insecticide pipeline with two U.S. Department of Defense grants totaling A$3 million, alongside key regulatory and production milestones for Flavocide® and Qcide®.

VRX Silica Limited has achieved a major milestone with the EPA recommending approval for its Arrowsmith North Silica Sand Project, alongside securing $5 million in capital and expanding offtake agreements.

Viridis Mining and Minerals has delivered a maiden Mixed Rare Earth Carbonate product with exceptional recovery rates, alongside a substantial resource upgrade at its Colossus Rare Earth Project in Brazil.

NeuRizer Ltd has resolved key regulatory delays for its NeuRizer Urea Project, significantly cut operating costs, and is forging international partnerships to expand its In Situ Gasification technology.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

Truscott Mining Corporation reports significant progress in its Tennant Creek gold projects, underpinned by robust research and plans for expanded drilling funded through new capital raising.

Richmond Vanadium Technology has submitted its draft Environmental Impact Statement for the Richmond - Julia Creek Vanadium Project and progressed innovative metallurgical test work, positioning itself for a development decision in 2025.

Bioxyne Limited has reported a remarkable 77% jump in revenue for Q2 FY2025, alongside positive operating cash flow, as it prepares to expand manufacturing capacity and enter new international markets.

OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.